Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement
India vaccinates 10 million in one day
28 August 2021Japan probes two deaths after jabs from tainted Moderna batch
28 August 2021Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement
The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale international study led by Mount Sinai.
